← Back to Search

Pain Management Strategies for Opioid Use Disorder

N/A
Recruiting
Led By Rebecca K McHugh, PhD
Research Sponsored by Mclean Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
age 18 years or older
Be older than 18 years old
Must not have
current peripheral neuropathy, active vasculitis or severe peripheral vascular disease
systematic inflammatory or autoimmune disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes

Summary

This trial will investigate whether people with opioid use disorder who have a better response to pain have less opioid craving.

Who is the study for?
This trial is for adults over 18 with chronic pain and diagnosed opioid use disorder who can read and consent to participate. It's not for those involuntarily in treatment, with recent heart issues, inflammatory/autoimmune diseases, on opioid pain meds, neuropathy, vasculitis, severe vascular disease or withdrawal.
What is being tested?
The study examines how education sessions about pain might influence the craving for opioids in individuals with an opioid use disorder. Participants will be randomly placed into one of two educational interventions and then assessed on their response to pain.
What are the potential side effects?
Since this trial involves educational interventions rather than medications or invasive procedures, significant side effects are not anticipated. However, discussing painful experiences could potentially cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have severe nerve, blood vessel, or circulation problems.
Select...
I have an inflammatory or autoimmune disorder.
Select...
I am currently taking opioid painkillers.
Select...
I have had a heart attack or serious heart condition recently.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Craving

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Pain De-CatastrophizingExperimental Treatment1 Intervention
Brief behavioral education on how to modify the interpretation of pain.
Group II: Pain EducationPlacebo Group1 Intervention
Brief behavioral education on pain.

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,605 Previous Clinical Trials
3,329,818 Total Patients Enrolled
Mclean HospitalLead Sponsor
217 Previous Clinical Trials
22,093 Total Patients Enrolled
Rebecca K McHugh, PhDPrincipal InvestigatorMclean Hospital
1 Previous Clinical Trials
37 Total Patients Enrolled

Media Library

Pain De-Catastrophizing Clinical Trial Eligibility Overview. Trial Name: NCT04190563 — N/A
Opioid Use Disorder Research Study Groups: Pain De-Catastrophizing, Pain Education
Opioid Use Disorder Clinical Trial 2023: Pain De-Catastrophizing Highlights & Side Effects. Trial Name: NCT04190563 — N/A
Pain De-Catastrophizing 2023 Treatment Timeline for Medical Study. Trial Name: NCT04190563 — N/A
~10 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top